Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina
February 20 2017 - 9:00AM
Business Wire
Illumina, Inc. (NASDAQ: ILMN) announced today that John W.
Thompson will join the company’s Board of Directors on May 3, 2017,
bringing extensive technology leadership experience to the
company.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170220005178/en/
John Thompson (Photo: Business Wire)
Mr. Thompson’s executive leadership experience includes having
served in chief executive officer roles at Symantec and Virtual
Instruments, as well as 28 years of prior leadership experience at
IBM where he held senior roles in sales, marketing, software
development, and as general manager of IBM Americas. He is chairman
of the board at Microsoft and has served on the corporate boards of
Symantec, NIPSCO (Northern Indiana Public Service Company), Fortune
Brands, Seagate Technologies, and United Parcel Service (UPS). Mr.
Thompson is a member of the board of trustees for the Wetlands
America Trust and formerly a member of the national board of Teach
for America. In addition, he has served on several government
commissions including the Financial Crisis Inquiry Commission, the
National Infrastructure Advisory Council, and the Silicon Valley
Blue Ribbon Task Force on Aviation Security and Technology.
“John brings a great breadth of knowledge and experience in the
public and private sectors having served in such a wide range of
leadership and advisory roles,” said Francis deSouza, Illumina
President and Chief Executive Officer. “His wealth of technology
expertise will help us continue to grow and scale our business in
the years to come.”
Mr. Thompson received his B.A. in business administration from
Florida A&M University and his M.S. in management science from
MIT’s Sloan School of Management.
About Illumina
Illumina is improving human health by unlocking the power
of the genome. Our focus on innovation has established us as the
global leader in DNA sequencing and array-based technologies,
serving customers in the research, clinical, and applied markets.
Our products are used for applications in the life sciences,
oncology, reproductive health, agriculture, and other emerging
segments. To learn more, visit www.illumina.com and
follow @illumina.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170220005178/en/
Illumina, Inc.Investors:Rebecca Chambers,
858-255-5243IR@illumina.comorMedia:Eric Endicott,
858-882-6822pr@illumina.com
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Sep 2023 to Sep 2024